Zacks Investment Research reporeted on Uranium Resources, Inc. (NASDAQ:URRE), bumping up its stock price target to $1.50 today
- Updated: September 17, 2016
Just yesterday Uranium Resources, Inc. (NASDAQ:URRE) traded 0.42% higher at $1.34. Uranium Resources, Inc.’s 50-day average is $1.47 and its two hundred day moving average is $1.92. With the last stock close down 24.40% relative to the two hundred day moving average, compared to the S&P 500 Index which has decreased -0.01% over the same period. Volume of trade was was down over the average, with 237,393 shares of URRE changing hands under the typical 759,128 shares..
Zacks Investment Research upped the target price of Uranium Resources, Inc. (NASDAQ:URRE) to $2, indicating a possible upside of 0.12%,
See Graph Below:
Uranium Resources, Inc. has a one-year low of $1.26 and a one-year high of $16.08 and has a market cap of $0.0.
More About Uranium Resources, Inc. (NASDAQ:URRE)
Uranium Resources, Inc. is a uranium exploration, development and production company. The Company has approximately 190, 000 acres of mineral holdings in the prolific Grants Mineral Belt of the State of New Mexico and approximately 14, 000 acres in the South Texas uranium province. Its uranium exploration and development activities are focused principally in the United States and the Republic of Turkey. The Company’s properties include Temrezli Project, Kingsville Dome Project, Rosita Project, Vasquez Project, Butler Ranch Project, Churchrock Project, Crownpoint Project, Cebolleta Project and Juan Tafoya Project. The Kingsville Dome property is located in Kleberg County. The Juan Tafoya Project is located approximately 45 miles west-northwest of Albuquerque. The Cebolleta project is located in west-central New Mexico. The Sejita Dome exploration project is located in southern Duval County, Texas. The Vasquez project is located in southwestern Duval County, and Texas.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.